Melasma

A review of treatments for melasma — including daily practices, topical treatments and oral options — targeted defining a standard of care for the chronic condition, especially among patients with skin of color, according to a study.

Topical tranexamic acid may be an alternative to hydroquinone for the long-term management of mild to moderate melasma, according to an expert consensus.

Silymarin cream may be an effective and tolerable alternative to hydroquinone in patients with melasma, according to a study.

Patients with hyperpigmentation disorders benefitted from a novel stabilized formulation of topical cysteamine, according to meta-analysis findings.

Microneedling with topical therapy is a safe and effective tool for the treatment of melasma, according to a presentation at the American Society for Dermatologic Surgery virtual meeting.

Microneedling combined with 10% trichloroacetic acid peels improved and maintained hyperpigmentation more than carbon dioxide laser resurfacing alone, according to a study presented at the American Academy of Dermatology virtual meeting.

When treating pigmentary disorders in Asian patients, the use of low-fluence picosecond Nd:YAG laser may be a more beneficial procedure, according to a poster presented at the American Academy of Dermatology virtual meeting.

Sunscreen with both UV and short visible light protection reduces melasma severity in patients with dark skin, according to a poster presented at the American Academy of Dermatology virtual meeting.

A triple combination cream containing hydroquinone, tretinoin and corticosteroid proved to be the most effective melasma intervention, according to findings of a recent review article.